Two rulings Friday keeping alive the common fund order are a ringing endorsement by the courts of the important role that litigation funders play in class actions, experts say, and have paved the way for more funded post-Hayne consumer litigation against banks and other financial services firms this year.
A senior female partner at Piper Alderman will go into mediation this week with representatives of the firm’s partnership to try to resolve her sex discrimination lawsuit, which alleges a group of equity partners have used baseless complaints of bullying to try to push her out.
Common fund orders in class actions are legal and not unconstitutional, six judges found Friday after a history-making joint sitting of two appeals courts.
The Australian Competition and Consumer Commission has suspended its timeline for announcing whether it will bless the proposed $15 billion merger of telco giants TPG and Vodafone Hutchison Australia, saying the parties have still not complied with its requests for information.
GetSwift has warned it may seek an injunction blocking Johnson Winter & Slattery from acting as instructing lawyers to the corporate cop in its enforcement action against the logistics company, saying the firm provided advisory work for it last year.
Maurice Blackburn has lost a long-running fight with the Australian Taxation Office over a tax bill on two massive class action settlements secured by the firm for thousands of Black Saturday bushfire victims.
A serviced apartments provider has discontinued its appeal of a ruling that blocked it from trade marking the phrase “Waldorf Apartment”, after Hilton Worldwide — which owns New York’s iconic Waldorf Astoria hotel – opposed the move.
The Victorian Supreme Court has awarded a couple $145,000 in damages from a construction firm that denied them access to their brand new $5.8 million apartment and art gallery in Melbourne’s Eureka Tower for 130 weeks.
A litigation funder wants the High Court to review a court decision’s to approve a $64 million settlement in litigation over the failure of Banksia Securities while rejecting the funder’s commission and legal fees.
Danish pharmaceutical giant Lundbeck secured $51.7 million in settlements to end infringement litigation with three generic makers over its patent for the top-selling Lexapro, the company has revealed.